Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Latest posts
Last updated about 13 hours ago
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 8, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of...
Human medicines European public assessment report (EPAR): Epysqli, eculizumab, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Epysqli, eculizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 33, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine...
Presentation - Why are NAMs important? (S. Ponzano)
about 14 hours ago
Presentation - Why are NAMs important? (S. Ponzano)
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation: 23/08/2022, Revision: 9, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Tecvayli, teclistamab, Date of authorisation...
Applications for new human medicines under evaluation: August 2026
about 14 hours ago
Applications for new human medicines under evaluation: August 2026
Human medicines European public assessment report (EPAR): Spedra, avanafil, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 17, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Spedra, avanafil, Date of authorisation...
Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation:
about 14 hours ago
Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular...
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisatio
about 14 hours ago
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular...
Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 23, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted)...